Infliximab Therapeutic Drug Monitoring in Clinical Practice: Indications and Utility

被引：0
|
作者：
McTigue, Michael [1 ]
Sandborn, William [1 ]
Levesque, Barrett [1 ]
Patel, Derek [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01703
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1703
引用
收藏
页码：S512 / S512
页数：1
相关论文
共 50 条
  • [31] Individual clearance and therapeutic drug monitoring of Quetiapine in clinical practice
    Wittmann, Markus
    Hausner, Helmut
    Koestlbacher, Anton
    Hajak, Goran
    Haen, Ekkehard
    NEUROENDOCRINOLOGY LETTERS, 2010, 31 (02) : 203 - 207
  • [32] Therapeutic drug monitoring in practice
    Hart, S.
    Hailwood, S.
    McLaren, J.
    SCOTTISH MEDICAL JOURNAL, 2019, 64 (03) : NP44 - NP44
  • [33] Therapeutic drug monitoring of risperidone: Relevance, clinical practice and interpretation
    Wittmann, Markus
    Bader, Wolfgang
    Hausner, Helmut
    Klein, Helmfried E.
    Haen, Ekkehard
    PSYCHIATRISCHE PRAXIS, 2007, 34 : S111 - S113
  • [34] Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice
    Pfuhlmann, B.
    Gerlach, M.
    Burger, R.
    Gonska, S.
    Unterecker, S.
    Jabs, B.
    Riederer, P.
    Deckert, J.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2007, (72): : 287 - 296
  • [35] Usefulness of therapeutic drug monitoring of antiretrovirals in routine clinical practice
    Duong, M
    Golzi, A
    Peytavin, G
    Piroth, L
    Froidure, M
    Grappin, M
    Buisson, M
    Kohli, E
    Chavanet, P
    Portier, H
    HIV CLINICAL TRIALS, 2004, 5 (04): : 216 - 223
  • [36] Therapeutic drug monitoring of gabapentin in various indications
    Burns, Margrete Larsen
    Kinge, Einar
    Opdal, Mimi Stokke
    Johannessen, Svein I.
    Landmark, Cecilie Johannessen
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 139 (05): : 446 - 454
  • [37] Analytical and clinical performance evaluation of two POC tests for therapeutic drug monitoring of infliximab
    Van den Bossche, Dorien
    De Smet, Dieter
    Debrabandere, Johan
    Vanpoucke, Hilde
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (06) : 856 - 863
  • [38] Clinical consequences of infliximab immunogenicity and the impact of therapeutic drug monitoring: secondary analyses of a randomised clinical trial
    Brun, M.
    Bjorlykke, K.
    Gehin, J.
    Warren, D.
    Klaasen, R.
    Sexton, J.
    Sandanger, O.
    Kvien, T.
    Mork, C.
    Jahnsen, J.
    Bolstad, N.
    Jorgensen, K.
    Haavardsholm, E.
    Goll, G.
    Syversen, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 43 - 45
  • [39] CLINICAL CONSEQUENCES OF INFLIXIMAB IMMUNOGENICITY AND THE IMPACT OF THERAPEUTIC DRUG MONITORING: SECONDARY ANALYSES OF A RANDOMISED CLINICAL TRIAL
    Brun, M. K.
    Bjorlykke, K. H.
    Gehin, J. E.
    Warren, D. J.
    Klaasen, R. A.
    Sexton, J.
    Sandanger, O.
    Kvien, T. K.
    Mork, C.
    Jahnsen, J.
    Bolstad, N.
    Jorgensen, K. K.
    Haavardsholm, E. A.
    Goll, G. L.
    Syversen, S. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 40 - 40
  • [40] Clinical utility of therapeutic drug monitoring of adalimumab using a point of care test
    Stevens, T.
    Teichert, C.
    Volkers, A.
    Montazeri, N. Mostafavi
    Bahur, B.
    Bray, K.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I504 - I505
12345